Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Total Liabilities (2018 - 2025)

Avai Bio's Total Liabilities history spans 7 years, with the latest figure at $1.8 million for Q1 2024.

  • On a quarterly basis, Total Liabilities rose 104.47% to $1.8 million in Q1 2024 year-over-year; TTM through Mar 2024 was $1.8 million, a 104.47% increase, with the full-year FY2024 number at $1.8 million, up 104.47% from a year prior.
  • Total Liabilities hit $1.8 million in Q1 2024 for Avai Bio, up from $1.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for AVAI hit a ceiling of $1.8 million in Q1 2024 and a floor of -$334124.0 in Q4 2020.
  • Historically, Total Liabilities has averaged $819638.6 across 5 years, with a median of $844537.0 in 2022.
  • Biggest five-year swings in Total Liabilities: tumbled 300.97% in 2020 and later skyrocketed 3134.77% in 2021.
  • Tracing AVAI's Total Liabilities over 5 years: stood at -$334124.0 in 2020, then skyrocketed by 442.29% to $1.1 million in 2021, then dropped by 27.92% to $824372.0 in 2022, then surged by 105.26% to $1.7 million in 2023, then rose by 5.7% to $1.8 million in 2024.
  • Business Quant data shows Total Liabilities for AVAI at $1.8 million in Q1 2024, $1.7 million in Q4 2023, and $1.3 million in Q3 2023.